Inventor
BECQ FREDERIC
FR9 patents
⚠️ This page may combine multiple inventors who share the name “BECQ FREDERIC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CENTRE NAT RECH SCIENT
6 patentsUS6630482B1Oct 7, 2003
CFTR channel activator compounds and pharmaceutical compositions containing same
CENTRE NAT RECH SCIENT26 citations85
US7973054B2Jul 5, 2011
Use of glucosidase inhibitors for therapy of mucovisidosis
CENTRE NAT RECH SCIENT7 citations78
US7605153B2Oct 20, 2009
Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
CENTRE NAT RECH SCIENT0 citations39
US7897610B2Mar 1, 2011
Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
CENTRE NAT RECH SCIENT0 citations37
US7772198B2Aug 10, 2010
CFTR channel modulators
CENTRE NAT RECH SCIENT0 citations32
US10414768B2Sep 17, 2019
Compounds for treating cystic fibrosis
CENTRE NAT RECH SCIENT0 citations26
BECQ FREDERIC
3 patentsUS8492420B2Jul 23, 2013
Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
BECQ FREDERIC1 citations47
US8242136B2Aug 14, 2012
Use of glucosidase inhibitors for therapy of mucovisidosis
BECQ FREDERIC0 citations43
US8252958B2Aug 28, 2012
Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells
BECQ FREDERIC0 citations39